Skip to main content

Cancer Center

The understanding of cancer is growing every day and our clinicians are making a significant impact on how the world researches, teaches and delivers care to improve quality and quantity of life.
Gennaro Carpinito, MD talking to a patient before he performs an urology surgery using DaVinci.
Leading the way in cancer care

At Tufts Medical Center Cancer Center, patients diagnosed with cancer can access a broad spectrum of specialized services. Our team comprises esteemed medical professionals, including hematologists, medical oncologists, radiation oncologists, surgeons, pathologists, nurses, social workers, researchers and other dedicated partners. Together, we work collaboratively to devise a comprehensive treatment strategy tailored to each patient's individual needs. Our approach involves close communication and coordination with the patient and the referring physician to ensure personalized care. 

We emphasize exceptional humanistic care and have a history of innovative approaches to the most complex issues. Our Bone Marrow and Hematopoietic Cell Transplant Program was the first program in Boston to be nationally certified as a transplant and donor collection center. Additionally, the Reid R. Sacco Adolescent and Young Adult (AYA) Program at Tufts Medical Center is the first program in Boston to deliver personalized, multidisciplinary care tailored to the patient's age and disease with emphasis on survivorship-based care including management of complications or late effects, such as fertility issues, bone issues or heart problems related to cancer treatments. This innovative thinking continues today on every project and with every patient interaction.

 

hands-growing

Our specialty areas

Our cancer centers, located in Boston, Framingham, Lowell and Stoneham, are widely recognized for offering exceptional cancer care to patients. Our comprehensive range of services encompasses every aspect of cancer care, from screening to research and survivorship, and we specialize in providing expert care to patients with diverse needs. Our team of highly trained physicians and specialists is dedicated to providing personalized and compassionate care that is tailored to meet the unique needs of each patient. We take pride in our commitment to providing the highest level of care and support to our patients throughout their cancer journey. Our ultimate goal is to ensure that our patients receive the best possible care and achieve the best possible outcomes.

 

lightbulb

Our institutes

Tufts Medical Center Cancer Center is at the forefront of revolutionizing cancer diagnoses, treatments, and outcomes worldwide. Our team of experts is committed to exploring the molecular mechanisms of multiple neoplasms and conducting clinical trials in collaboration with the Neely Foundation. Our physicians serve as principal investigators on national cancer clinical trials with the Alliance for Clinical Trials in Oncology and affiliated cooperative groups, including the Eastern Cooperative Oncology Group (ECOG). We also conduct pharmaceutical studies and investigator-initiated trials with significant funding from the National Institutes of Health, the Department of Defense, and cancer research-focused foundations. Through these studies, we have access to cutting-edge diagnostics and novel treatment agents, which enable us to make positive changes to our clinics and bedside care.

We are very fortunate to have the ability to collaborate with a variety of other researchers and research institutes at Tufts University, including the Jean Mayer USDA Human Nutrition Research Center on Aging (HNRCA) at Tufts University, Cummings School of Veterinary Medicine at Tufts University (TCSVM), Tufts University School of Biomedical Sciences, Tufts Clinical and Translational Sciences Institute, the Institute for Clinical Research and Health Policy Studies, the Tufts Center for the Study of Drug Development, the Tufts Center for Evaluation in Health, and the Biostatistics, Epidemiology, and Research Design Center.

Supporting + core services

Jatin Roper, MD, Director of the Center for Hereditary Gastrointestinal Cancer at Tufts Medical Center and Chelsea Mandigo, Genetic Counselor in laboratory using a pipet for a genetics test.
Research

Neely Center for Clinical Cancer Research

The Neely Center for Clinical Cancer Research (NCCCR) is a cutting-edge facility that translates fundamental research findings into practical clinical applications to improve patient outcomes. The Center collaborates with industry professionals, clinicians and academic researchers to develop innovative cancer treatments. The NCCCR serves as the core facility of the Cancer Center, coordinating all aspects of oncology and hematology clinical research in compliance with NIH rules, FDA regulations and "Good Clinical Practice" guidelines.

A clinical trial investigating BNT113 in combination with pembrolizumab versus pembrolizumab alone for patients with a form of head and neck cancer positive for human papilloma virus 16 and expressing the protein PD-L1
medical-cross
Head and neck cancer
user
All genders
person-wave 18+
world
Recruiting now
Learn more
A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in Participants With Essential Thrombocythemia and an Inadequate Response or Intolerance of Hydroxyurea (MK-3543-006)
user
All genders
person-wave 18+
world
Recruiting now
Learn more
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin (VOLGA)
medical-cross
Bladder cancer
user
All genders
person-wave 18+
world
Recruiting now
Learn more
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer (OPERA-01)
medical-cross
Breast cancer, Locally advanced and metastatic breast cancer
user
All genders
person-wave 18+
world
Recruiting now
Learn more
Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial
medical-cross
Breast cancer
user
All genders
person-wave 18+
world
Recruiting now
Learn more
To Evaluate Efficacy and Safety of HLX10 + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC
medical-cross
Small cell lung cancer
user
All genders
person-wave 18+
world
Recruiting now
Learn more
CAR-T detection by IVFC
medical-cross
Lymphoma
user
All genders
person-wave 18+
world
Recruiting now
Learn more
An Observational Study of Patients Receiving T-DXd for Treatment of HER2+, and HER2-low Unresectable and/​or Metastatic Breast Cancer
medical-cross
Breast cancer
user
All genders
person-wave 16+
world
Recruiting now
Learn more
Breast Cancer Database
medical-cross
Breast cancer
user
All genders
person-wave 18+
world
Recruiting now
Learn more
A Study of DSP-5336 in Relapsed/​Refractory AML/​ ALL With or Without MLL Rearrangement or NPM1 Mutation
medical-cross
Relapsed refractory myeloma
user
All genders
person-wave 18+
world
Recruiting now
Learn more
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
medical-cross
Breast cancer
user
All genders
person-wave 18+
world
Recruiting now
Learn more
Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma (XPORT-EC-042)
medical-cross
Endometrial cancer
user
All genders
person-wave 18+
world
Recruiting now
Learn more
Multi-spectral imaging
medical-cross
Ovarian cancer
user
Female
person-wave 18-99
world
Recruiting now
Learn more
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US)
medical-cross
Colon cancer
user
All genders
person-wave 18+
world
Recruiting now
Learn more
EAQ202
medical-cross
Cancer
user
All genders
person-wave 18-39
world
Recruiting now
Learn more
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
medical-cross
Squamous cell carcinoma
user
All genders
person-wave 18+
world
Recruiting now
Learn more
Perioperative versus adjuvant chemotherapy for pancreatic cancer
medical-cross
Pancreatic cancer
user
All genders
person-wave 18+
world
Recruiting now
Learn more
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
medical-cross
Lymphomas (adult)
user
All genders
person-wave 18+
world
Recruiting now
Learn more
A Modified Ketogenic, Anti‐Inflammatory Diet for Patients with High‐Grade Gliomas
medical-cross
Glioblastoma
user
All genders
person-wave 18+
world
Recruiting now
Learn more
Non-Interventional Fresh Tumor Tissue
medical-cross
Glioblastoma
user
All genders
person-wave 18+
world
Recruiting now
Learn more
Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma
medical-cross
Diffuse large B-cell lymphoma
user
All genders
person-wave 75+
world
Recruiting now
Learn more
Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients
medical-cross
Cancer
user
All genders
person-wave 18+
world
Recruiting now
Learn more
A Study of Daratumumab-Based Therapies
medical-cross
Amyloidosis
user
All genders
person-wave 18+
world
Recruiting now
Learn more
A Study of the Pharmacokinetics, Safety, and Efficacy of ASTX727
medical-cross
Acute myeloid leukemia (AML)
user
All genders
person-wave 18+
world
Recruiting now
Learn more

Training + Education

Our comprehensive training programs provide extensive education on benign and malignant hematology, hemostasis, thrombosis, advanced hematopoietic cellular therapies, solid tumor malignancies, and other relevant topics. Our program equips physicians with the necessary tools for diverse career paths, and many of our graduates have established themselves as leaders in academic medicine, clinical practice, industry and health policy.

  • Hematology/Oncology Fellowship
    Our Hematology/Oncology Fellowship program offers exceptional training in clinical instruction and research, resulting in graduates who excel as leaders in academic hematology and medical oncology. Our accomplished alumni lead prominent programs globally, manage transfusion medicine programs in hospitals nationwide, and hold esteemed editorial positions in renowned journals.
  • Radiation Oncology Residency Program
    The Radiation Oncology Residency Program trains board-certified radiation oncologists with essential skills to practice autonomously. We foster an inclusive community and provide care to a wide range of patients. Trainees receive ample one-on-one time with distinguished faculty and participate in weekly didactic training.

Our leadership

Our leadership team provides us with the guidance and support we need to ensure that the department's clinical, research, and training goals are met.

  • Director, Tufts Medical Center Cancer Center and Chief, Division of Hematology Oncology: Rachel Buchsbaum, MD
  • Chief, Division of Surgical Oncology: Martin Goodman, MD
  • Chief, Division of Gynecologic Oncology: Katina Robison, MD
  • Chair of Radiation Oncology: Matthew Katz, MD
  • Chair of ENT: Miriam O’Leary, MD
  • Chair of Genito-Urinary Surgery: Gino Carpinito, MD
  • Chair of Neurosurgery: Carl Heilman, MD
  • Chair of Pathology: Ming Zhou, MD
  • Chair of Radiology: Daichi Hayashi, MD, PhD
  • Chief, Genetics: Dallas Reed, MD
  • Director, Bone Marrow + Stem Cell Transplant and Cellular Therapies: Andreas Klein, MD
  • Associate Program Director, Hematology Oncology Fellowship Program: Lori Pai, MD
  • Associate Program Director, Hematology Oncology Fellowship Program: Jacob Elkon, MD
  • Program Director, Radiation Oncology Residency Program: Matthew Katz, MD
Anasuya Gunturi MD, PhD talks with patient at Lowell General Hospital's Women's Wellness Center clinic appointment.
Our locations

From regular office visits to inpatient stays, our specialists across Tufts Medicine offer the best in healthcare, when and where our patients need it.

Andreas Klein, MD of Tufts Medical Center's Cancer Center talking to patient in a clinic appointment.
Our doctors + care team

Our specialists and care team members across Tufts Medicine deliver unmatched healthcare with a personalized touch.

Jump back to top